5-(CHLOROMETHYL)-3-(3-FLUORO-4-(6-(2-METHYL-2H-TETRAZOL-5-YL)-3-PYRIDINYL)PHENYL)-2-OXAZOLIDINONE, (5R)-
UNII 3PP7EV46FM
Substance Identification & Data
This profile provides standardized clinical and technical data for 5-(chloromethyl)-3-(3-fluoro-4-(6-(2-methyl-2h-tetrazol-5-yl)-3-pyridinyl)phenyl)-2-oxazolidinone, (5r)-, uniquely identified by the FDA Unique Ingredient Identifier (UNII) 3PP7EV46FM.
Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 1239662-46-4 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.
Detailed Substance Profile
C17H14ClFN6O2 XBEWJWSQISOVRV-LBPRGKRZSA-N Synonyms and Nomenclature
This section provides a complete list of nomenclature and identifier mappings for 5-(chloromethyl)-3-(3-fluoro-4-(6-(2-methyl-2h-tetrazol-5-yl)-3-pyridinyl)phenyl)-2-oxazolidinone, (5r)-. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.